PFG Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.72M | Buy |
5,172
+92
| +2% | +$51.6K | 0.14% | 181 |
|
|
2026
Q1 | $2.85M | Buy |
5,080
+28
| +0.6% | +$18K | 0.14% | 184 |
|
|
2025
Q4 | $3.42M | Sell |
5,052
-6,980
| -58% | -$4.75M | 0.17% | 146 |
|
|
2025
Q3 | $7.69M | Buy |
12,032
+461
| +4% | +$280K | 0.31% | 77 |
|
|
2025
Q2 | $6.21M | Buy |
11,571
+1,196
| +12% | +$572K | 0.29% | 71 |
|
|
2025
Q1 | $4.36M | Buy |
10,375
+2,910
| +39% | +$1.26M | 0.24% | 105 |
|
|
2024
Q4 | $3.09M | Buy |
7,465
+50
| +0.7% | +$21.9K | 0.19% | 129 |
|
|
2024
Q3 | $3.75M | Sell |
7,415
-658
| -8% | -$320K | 0.24% | 101 |
|
|
2024
Q2 | $3.93M | Sell |
8,073
-41
| -0.5% | -$20.6K | 0.27% | 90 |
|
|
2024
Q1 | $4.38M | Sell |
8,114
-961
| -11% | -$525K | 0.32% | 71 |
|
|
2023
Q4 | $5.04M | Sell |
9,075
-410
| -4% | -$192K | 0.41% | 60 |
|
|
2023
Q3 | $4.15M | Sell |
9,485
-86
| -0.9% | -$42.9K | 0.37% | 67 |
|
|
2023
Q2 | $4.81M | Buy |
9,571
+115
| +1% | +$55.1K | 0.37% | 67 |
|
|
2023
Q1 | $4.73M | Sell |
9,456
-128
| -1% | -$61.3K | 0.4% | 59 |
|
|
2022
Q4 | $3.91M | Buy |
9,584
+661
| +7% | +$257K | 0.38% | 59 |
|
|
2022
Q3 | $2.91M | Buy |
8,923
+35
| +0.4% | +$12.9K | 0.33% | 70 |
|
|
2022
Q2 | $3.12M | Sell |
8,888
-502
| -5% | -$205K | 0.35% | 58 |
|
|
2022
Q1 | $5.14M | Buy |
9,390
+964
| +11% | +$507K | 0.51% | 31 |
|
|
2021
Q4 | $5.55M | Buy |
8,426
+147
| +2% | +$92.3K | 0.55% | 34 |
|
|
2021
Q3 | $5.15M | Sell |
8,279
-542
| -6% | -$364K | 0.57% | 31 |
|
|
2021
Q2 | $5.57M | Buy |
8,821
+364
| +4% | +$201K | 0.64% | 27 |
|
|
2021
Q1 | $4.14M | Buy |
8,457
+377
| +5% | +$189K | 0.53% | 40 |
|
|
2020
Q4 | $4.04M | Sell |
8,080
-190
| -2% | -$85K | 0.68% | 31 |
|
|
2020
Q3 | $3.19M | Buy |
8,270
+120
| +1% | +$44.4K | 0.61% | 39 |
|
|
2020
Q2 | $2.76M | Sell |
8,150
-315
| -4% | -$91.2K | 0.62% | 38 |
|
|
2020
Q1 | $2.26M | Sell |
8,465
-309
| -4% | -$80.6K | 0.61% | 42 |
|
|
2019
Q4 | $2.38M | Buy |
8,774
+492
| +6% | +$130K | 0.58% | 45 |
|
|
2019
Q3 | $2.25M | Buy |
8,282
+334
| +4% | +$92.9K | 0.62% | 40 |
|
|
2019
Q2 | $2.26M | Sell |
7,948
-5
| -0.1% | -$1.23K | 0.61% | 39 |
|
|
2019
Q1 | $1.84M | Sell |
7,953
-365
| -4% | -$75.3K | 0.56% | 41 |
|
|
2018
Q4 | $1.74M | Buy |
+8,318
| New | +$1.71M | 0.55% | 47 |
|
Other funds holding IDXX
PFG Advisors's IDXX Position: Q2 2026 in Review
PFG Advisors increased its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, buying an estimated $51.6K and bringing the position to 5,172 shares worth $2.72M. The position accounts for 0.14% of the portfolio, ranked #181.
PFG Advisors first reported a position in IDXX in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.69M in Q3 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- PFG Advisors held 5,172 shares of Idexx Laboratories worth $2.72M as of Q2 2026.
- PFG Advisors bought 92 Idexx Laboratories shares in Q2 2026, an estimated $51.6K.
- Idexx Laboratories made up 0.14% of PFG Advisors's portfolio in Q2 2026, its #181 holding.
- PFG Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 31 quarters since.
- PFG Advisors's Idexx Laboratories position peaked at $7.69M in Q3 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.